RedHill Biopharma logo
RedHill Biopharma
RDHL | NASDAQ
Chart Builder DCF Calculator
$0.46
-$0.05 (-9.32%)
At close: Oct 21, 2026, 4:00 PM ET

RedHill Biopharma Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
286K 8.04M 6.53M 61.8M 85.76M 64.36M
– 3.19M 3.46M 33.34M 49.41M 36.89M
286K 4.85M 3.07M 28.46M 36.35M 27.47M
-7.91M -14.61M 12.63M -42.84M -81.14M -63.68M
23K 133K 94K 140K 51K 176K
-8.08M -8.27M 23.92M -71.67M -97.74M -76.17M
-429K -8.27M 23.92M -71.67M -97.74M -76.17M
6.17M 15.52M 30.98M 64.03M 87.99M 74.66M
2.02M 1.59M 3.53M 7.28M 29.5M 16.49M
– 2.36M -44.06M – – –
8.2M 19.46M -9.56M 71.31M 117.49M 91.15M
19K 55K 367K 41.33M 16.57M 12.45M
– 1M 2.1M 9.06M 11.39M 49.29M
8.2M 22.66M -6.1M 104.64M 166.89M 128.04M
– – – – – –
3.16M 2.46M 518.24K 123.86K 93.05K 72.85K
3.16M 2.46M 518.24K 123.86K 93.05K 72.85K
– -7 46 -600 -1K -1K
– -7 46 -600 -1K -1K
-7.65M -7.59M 26.27M -22.18M -63.03M -54.98M
-8.06M -8.21M 24.28M -30.34M -81.18M -63.72M
409K 619K 1.99M 8.15M 18.15M 8.75M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.